Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Axim Biotechnologies, Inc. (OTC: AXIM).

Full DD Report for AXIM

Recent News from (OTC: AXIM)

AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities
NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech ), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has published a patent application owned by the Company for an ...
Source: GlobeNewswire
Date: April, 18 2018 09:00
5 of Today's Biggest Marijuana Stock Losers - Monday, April 9th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, April 9th including Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF) and more... Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF) Shares of Aurora Cannabis Inc. dropped 7.90% today on high...
Source: Daily Marijuana Observer
Date: April, 09 2018 17:19
Marijuana Stocks: Winners and Losers April 4, 2018
Marijuana stocks reversed their fortunes on Wednesday as strong gains permeated the market. It was the first day of positive gains for weed stocks in almost a week. Below are the top winners and losers in the pot stock market for April 4, 2018: Axim Biotechnologies, Inc. Axim Biotechnologi...
Source: Pot News
Date: April, 05 2018 03:41
5 of Today's Biggest Marijuana Stock Gainers - Wednesday, April 4th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Wednesday, April 4th including WeedMD Inc. (TSXV:WMD) (OTC:WDDMF) and more... Axim Biotechnologies, Inc. (OTC:AXIM) Shares of Axim Biotechnologies, Inc. rose 15.75% on higher than averag...
Source: Daily Marijuana Observer
Date: April, 04 2018 17:42
Marijuana Stocks: Winners and Losers April 3, 2018
Another rough day for marijuana stocks was spurred on by some of Canada’s more prominent Licensed Producers On Monday. Conversely, the medical marijuana sector is holding strong during the market’s current volatile phase. Here are the winners and losers of the marijuana stock mar...
Source: Pot News
Date: April, 04 2018 05:51
AXIM Biotechnologies Inc. Uses Solventless Extraction with the First Current Good Manufacturing Processes in American Cannabis
AXIM Biotechnologies Inc. (OTC:AXIM)  announced  the execution of their proprietary current good manufacturing practices (cGMP) methodology for extracting and encapsulating cannabis oil. In February, they became the first cannabis company to perform this exclusive method of extract...
Source: Pot News
Date: April, 04 2018 04:36
5 of Today's Biggest Marijuana Stock Gainers - Tuesday, April 3rd
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Tuesday, April 3rd including GW Pharmaceuticals Plc. (NASDAQ:GWPH) and more... Axim Biotechnologies, Inc. (OTC:AXIM) Shares of Axim Biotechnologies, Inc. rose 9.59% on lower than average...
Source: Daily Marijuana Observer
Date: April, 03 2018 18:44
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a Memo of Understanding (“MOU”) with a leading...
Source: GlobeNewswire
Date: April, 03 2018 09:00
5 of Today's Biggest Marijuana Stock Losers - Thursday, March 29th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Thursday, March 29th including AXIM Biotechnologies Inc. (OTC:AXIM) and more... Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) Shares of Abattis Bioceuticals Corp. dropped 6.07% toda...
Source: Daily Marijuana Observer
Date: March, 29 2018 16:51
AXIM Biotech to Attend BioCentury's 25th Annual Future Leaders in the Biotech Industry Conference in New York
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM Biotech, is scheduled to m...
Source: GlobeNewswire
Date: March, 21 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-215.415.325.425.2112,587
2018-04-205.415.325.425.2112,587
2018-04-195.395.425.425.2320,592
2018-04-185.335.355.455.3135,151
2018-04-175.345.335.585.3049,952

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-202,36112,55118.8113Cover
2018-04-195,15416,94830.4107Cover
2018-04-188,84127,75131.8583Cover
2018-04-1718,75240,41846.3952Short
2018-04-1630,12160,71149.6137Short

* Cover Mode

Short Analysis provided by Squeeze Report.


About Axim Biotechnologies, Inc. (OTC: AXIM)

Logo for Axim Biotechnologies, Inc. (OTC: AXIM)

AXIM Biotechnologies is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products as well as alternative sources of energy. We prioritize the well being of our customers while embracing a solid fiscal strategy. We believe to be setting the green standard for cannabinoid bioscience through the discovery and commercialization of new materials and technologies for healthy living, all while respecting the environment.

 

Contact Information

 

 

Current Management

  • George E. Anastassov / CEO, President
  • Robert Malasek / CFO
  • Lekhram Changoer / CTO
  • Philip A. Van Damme / Chief Scientific Officer
  • George E. Anastassov / Chairman
  • Timothy R Scott / Director, Audits, Independent Director
  • Lekhram Changoer /
  • Robert Cunningham / Independent Director
  • Philip A. Van Damme /
  • John W Huemoeller II / Independent Director
  • Blake N. Schroeder /

Current Share Structure

  • Market Cap: $270,093,983 - 03/15/2018
  • Authorized: 300,000,000 - 09/30/2016
  • Issue and Outstanding: 54,564,441 - 11/17/2017
  • Float: 35,206,500 - 01/23/2017

 


Recent Filings from (OTC: AXIM)

Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: April, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 05 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: November, 15 2017
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: September, 14 2017
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: September, 14 2017
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: September, 14 2017
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: September, 14 2017

 

 


Daily Technical Chart for (OTC: AXIM)

Daily Technical Chart for (OTC: AXIM)


Stay tuned for daily updates and more on (OTC: AXIM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AXIM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AXIM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of AXIM and does not buy, sell, or trade any shares of AXIM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us